Table 2 Enoxaparin dosing practice
All patients (n = 602) | Bleeding Events | p-value | ||
|---|---|---|---|---|
Bleeding (n = 95) | Non-bleeding (n = 507) | |||
Dose, mg/kg (mean ± SD) | 0.91 ± 0.25 | 0.94 ± 0.24 | 0.91 ± 0.25 | 0.302 |
Dose of enoxaparin, n (%) | ||||
Recommended dose | 255 (42.4) | 43 (16.9) | 212 (83.1) | 0.532 |
Lower than recommended dose | 292 (48.5) | 39 (13.4) | 253 (86.6) | 0.113 |
Excess than recommended dose | 55 (9.1) | 13 (23.6) | 42 (76.4) | 0.094 |
Total dose, mg/kg (mean ± SD) | 6.83 ± 7.32 | 6.24 ± 6.48 | 6.94 ± 7.47 | 0.393 |
Duration of enoxaparin therapy, days (mean ± SD) | 4.3 ± 4.4 | 3.7 ± 3.6 | 4.4 ± 4.5 | 0.151 |
Doses administered, doses (IQR) | 6 (3–9) | 5 (3–8) | 6 (3–9) | 0.238 |